A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Harvard University, Cornell University, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Broad Institute, Medical University of South Carolina, University of California, Davis, University of California, San Francisco, City of Hope, Naggalama Hospital, St. Francis Referral Hospital, St Francis Chronic Hospital, St. Francis Hospital, St Francis’ Hospital, AstraZeneca (Singapore), AstraZeneca (Sweden), University of Louisville, University of Louisville Hospital, James Graham Brown Foundation